Cosan (CSAN3) shares closed the last trading session on Friday, December 6, at R$ 2.77, up 10.80%. It marked the third consecutive daily gain, driven by two catalysts: UBS-BB upgraded the stock to buy, and reports circulated regarding a potential sale of a stake in Compass. Even so, the stock still trades at nearly half its value prior to the October sell-off.
Where Does CSAN3 Stand Today and What Does the Chart Show?
Because markets are closed on Saturdays, Friday's close governs: according to *Money Times*, Cosan led the gainers on the Ibovespa, closing the session up 10.80% at R$ 2.77. Prior to that, according to *TradeMap*, the shares rose 5.29% on Wednesday, December 4, and 4.60% on Thursday, December 5. Across the three sessions, the gain totals roughly 22% over Tuesday's close (December 3), which, working backward from the daily variations, stood near R$ 2.27.
The sell-off occurred in a single day. According to a market survey published on Friday, the stock closed at R$ 5.20 on Friday before the second round of the presidential election (October 23) and plunged 46.7% in the first trading session afterward. In our analysis of the October 26 drop, we noted that Cosan had disclosed no new material facts that day. From a technical analysis perspective, Investing.com points out that initial resistance levels stand at R$ 2.81 and R$ 2.93, while the recent low of R$ 2.16 serves as the primary support reference. However, the charts do not explain why UBS-BB changed its stance.
What Did UBS-BB Say About Cosan?
On Thursday (5), the bank upgraded its rating from neutral to buy. According to *Money Times*, the bank believes the market overreacted in penalizing the company, which has fallen roughly 40% in a month and trades at a 35% to 45% discount relative to the sum of its assets. The report is authored by Matheus Enfeldt, Tasso Vasconcellos, and Alberto Valerio.
This discount forms the core of the argument. Cosan is a holding company: its value derives from its equity stakes in Rumo, Compass, Raízen, and other enterprises, minus the holding company's own debt. To arrive at the target price, according to *Seu Dinheiro*, UBS-BB utilizes a sum-of-the-parts (SOTP) methodology, incorporating the individual price targets for Rumo, Compass, and Raízen. Consequently, Cosan's target depends directly on the bank's projections for each controlled subsidiary:
| Company | UBS-BB Rating | Price Target |
|---|---|---|
| Cosan (CSAN3) | Buy (was Neutral) | R$ 4.70 |
| Rumo (RAIL3) | Buy | R$ 22 |
| Compass (PASS3) | Buy | R$ 38 |
| Raízen (RAIZ4) | Sell | R$ 0.16 |
Raízen maintains a sell rating, which weighs heavily on the thesis. The Shell joint venture in Brazil has proven to be the group's primary operational headache, as we detailed in our analysis of RAIZ4's decline. In practice, the bank assigns value to Cosan primarily through Rumo and Compass while treating Raízen's contribution as nearly zero. The question is how much the stock might appreciate if the broader market aligns with the bank's view.
How Much Can CSAN3 Gain if the Holding Company Discount Narrows?
The upside to the target sits at roughly 70% above Friday's close (our calculation: 4.70 ÷ 2.77). To justify this figure, UBS-BB argues that an appropriate holding discount would be 20% to 30% if the company maintains its current structure, or 10% to 20% if it advances toward eventual dissolution—an objective management has previously targeted for the next three to five years.
We can isolate the discount effect. Holding the underlying asset values constant, moving the discount from the midpoint of its current range (40%) to another tier shifts the stock price proportionally based on the residual value in each scenario. This remains our own estimate and assumes no capital appreciation in the operating subsidiaries:
The market continues to price in debt risk, and the stock merely tracks its subsidiaries.
Holding structure retained, discount at the midpoint of the bank's fair range (0.75 ÷ 0.60).
Dissolution advances and shareholders gain direct exposure to subsidiaries (0.85 ÷ 0.60).
The remainder of the path to the target depends on Rumo and Compass reaching the bank's projected valuations. Compass, for instance, traded up 5.06% at R$ 20.57 around 1:30 PM on Friday, well below its R$ 38 target. However, all this optimism runs up against a figure highlighted in the bank's own report.
What Could Go Wrong: Interest Rates and Debt
The primary risk lies in the cost of debt. According to *Seu Dinheiro*, assuming an interest rate environment of 15% in 2027, UBS-BB projects that Cosan's interest coverage ratio (ICR) will drop to 0.6x, down from an estimated 1.2x for 2026. Below 1.0x, distributions received from subsidiaries fail to cover interest expenses. Management has previously stated it considers a ratio between 1.5x and 2.0x appropriate, but the bank projects that level will not be reached until 2029 or 2030 if interest rates remain near 15%.
UBS-BB views this risk as a slow-burn issue rather than an immediate crisis: the institution notes it sees no immediate liquidity risks, despite cash generation pressures from high interest rates. Our Cosan profile from October 29 echoes this outlook. Net debt stands at 8.5x EBITDA compared to a historical median of 3.7x, and our fundamental score sits at 4.5 out of 10. The bank's upgrade does not alter these metrics; rather, it shifts the valuation perspective, suggesting the market over-penalized known risks.
Historical context is worth noting. In September 2025, according to *Seu Dinheiro*, UBS-BB downgraded Cosan from buy to neutral following a 40% drop over the preceding month. Now, the bank has upgraded the stock following a sell-off of similar magnitude. Investors who bought back then remain underwater, which explains why the next catalyst carries such weight.
Does the Compass Stake Sale Change the Equation?
It could, as it represents the sole viable lever to reduce debt in the near term. According to Investing.com, Friday's rally followed a report by *Valor Econômico*'s *Pipeline* column indicating that the holding company is in advanced talks to sell a 25% stake in Compass—the parent company of Comgás—to an Abu Dhabi state-backed fund. Bradesco BBI estimates the stake is worth roughly R$ 3.5 billion based on Compass's market valuation, though this does not represent a negotiated transaction price.
By our calculations, that amount would cover about 29% of the holding company's R$ 12.2 billion net debt from the second quarter. One media outlet reported 38%, a figure management has not confirmed. Cosan holds a 76.18% stake in Compass according to Q2 financial statements, meaning it would retain control even after the transaction. Two caveats apply: first, Cosan informed journalists it would not comment and, as of Friday afternoon, had issued no official material fact filing; second, UBS-BB does not incorporate divestments into its base case. A confirmed sale would represent upside to the bank's thesis. Negotiations regarding Rumo, by contrast, ultimately collapsed without an agreement, as we covered in our analysis of the end of the Rumo talks.
Does CSAN3 Pay Dividends? And What Should Investors Watch Now?
Cosan has not paid dividends since 2024. The last distribution was R$ 0.4515 per share, with an ex-date of June 6, 2024, and Status Invest records zero distributions over the trailing 12 months. With interest coverage below management's preferred threshold, cash allocation remains prioritized for debt reduction. Payouts are not on the horizon. Recent positive news arrived on a different front: an agreement with federal tax authorities, detailed in our tax settlement analysis, eliminated R$ 3.2 billion in tax contingencies with a cash outlay of R$ 200 million.
The bank's upgrade removes the "distressed stock" label and establishes a fair value benchmark for the holding company. However, the debt load remains unchanged. Investors who bought prior to October 23 are still sitting on losses near 47%. For those holders, this rebound offers no reason to aggressively buy more or panic-sell; decisions should depend on whether the Compass stake sale materializes and whether upcoming earnings reports confirm cash stability. For prospective buyers, the bank's thesis represents a long-term bet contingent on declining interest rates.
The first test has a scheduled date. According to Investing.com, the next hurdle is the Q3 earnings release scheduled for after the market close on November 13, when investors can evaluate debt progress and holding company cash generation. Three figures will matter most: net debt relative to the R$ 12.2 billion reported in Q2, dividends received from operating subsidiaries during the semester, and any official announcements regarding Compass.
Summary: UBS-BB presents a solid case that Cosan has grown undervalued. Trading at a 35% to 45% discount, the share price prices in severe pessimism. However, the bank also projects that interest coverage will deteriorate in 2027 if the Selic rate remains at 15%. This week's rally priced in hope. Confirmation requires a completed Compass sale via an official material fact filing and a healthy November 13 earnings report. Consequently, we maintain a "watch" rating.
